Suven Pharmaceuticals informs about credit rating

28 Feb 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Suven Pharmaceuticals has informed that the CRISIL has assigned/ reaffirmed the ratings to the Bank facilities of the Company as per letter received on February 28, 2025. The said letter is annexed.

The above information is a part of company’s filings submitted to BSE.

Suven Pharma Share Price

1132.75 23.45 (2.11%)
28-Mar-2025 10:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.45
Dr. Reddys Lab 1144.05
Cipla 1441.70
Lupin 2026.50
Zydus Lifesciences 885.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...